Summary
The time-courses of plasma carbamazepine concentrations were followed in six apparently healthy adult subjects who, at different times, took single oral drug doses of 200, 400, 500, 600, 700, 800 and 900 mg. There were some suggestions of impaired bioavailability of the drug when given in tablet form. The following values were obtained for various pharmacokinetic parameters:k abs =0.176±0.209 h−1;k=0.0203±0.0055 h−1; T1/2=37.5±13.1 h; VD=0.825±0.1041 · kg−1; Clearance=0.0163±0.0061 l · kg−1. The elimination rate constant showed a statistically significant increase with increasing drug dose. This may help explain the clinical observation that the rate of rise of steady state plasma carbamazepine concentrations tends to decrease with dose increase in patients taking carbamazepine alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Eichelbaum, M., Ekbom, D., Bertilsson, L., Ringberger, V.A., Rane, A.: Plasma pharmacokinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Europ. J. clin. Pharmacol.8, 337–341 (1975)
Friel, P., Green, J.R.: Quantitative assay for carbamazepine serum levels by gas-liquid chromatography. Clin. Chim. Acta43, 69–72 (1973)
Gerardin, A.P., Abadie, F.V., Campestrini, J.A., Theobald, W.: Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses. J. Pharmacokinet. Biopharm.4, 521–535 (1976)
Gibaldi, M., Perrier, D.: Pharmacokinetics. New York: Marcel Dekker 1975
Hooper, W.D., Dubetz, D.K., Eadie, M.J., Tyrer, J.H.: Preliminary observations on the clinical pharmacology of carbamazepine (Tegretol). Proc. Aust. Ass. Neurol11, 189–198 (1974)
Lander, C.M., Eadie, M.J., Tyrer, J.H.: Factors influencing plasma carbamazepine concentrations. Clin. Exp. Neurol.14 (1977 in press)
Levy, R.H., Pitlick, W.H., Troupin, A.S., Green, J.R., Neal, J.M.: Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol Therap.17, 657–668 (1975)
Morselli, P.L., Gerna, M., De Maio, D., Zanda, G., Viani, F., Garattini, S.: Pharmacokinetic studies on carbamazepine in volunteers and in epileptic patients in “Clinical pharmacology of antiepileptic drugs”, ed. Schneider, H., Janz, D., Gardner-Thorpe, C., Meinardi, H., Sherwin, A.L., p. 166–179. Berlin-Heidelberg-New York: Springer 1975
Rawlins, M.D., Collste, P., Bertilsson, L., Palmer, L.: Distribution and elimination kinetics of carbamazepine in man. Europ. J. clin. Pharmacol.8, 91–96 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cotter, L.M., Eadie, M.J., Hooper, W.D. et al. The pharmacokinetics of carbamazepine. Eur J Clin Pharmacol 12, 451–456 (1977). https://doi.org/10.1007/BF00561065
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561065